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1. Introduction 
Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disorder affecting 
multiple organ systems. 30-40 % of the patients manifest variable neuropsychiatric 
symptoms leading to significant morbidity and mortality. CNS involvement could be 
primary if directly related to SLE activity in the CNS or secondary to treatment, infections, 
metabolic abnormalities or other systemic manifestations such as hypertension (Futrell et 
al,1992). Primary NPSLE is divided into focal and diffuse disease. Focal NPSLE is 
characterized by focal neurologic deficits and is strongly associated with the occurrence of 
thromboembolic events. Diffuse primary NPSLE is a group of neurologic, psychiatric, and 
cognitive syndromes that vary from overt neurologic and psychiatric symptoms (eg. 
seizures, psychosis) to more subtle signs such as headache, mood disturbances, anxiety 
disorders or mild cognitive dysfunction. Neuropsychiatric lupus (NPSLE) manifestations 
can occur in the absence of either serologic activity or other systemic disease manifestations 
(Sibbit et al., 1999). Thus, in clinical practice the diagnosis of primary NPSLE is rather 
presumptive, after the exclusion of alternative causes of the neuropsychiatric symptoms. 
There is no single diagnostic test that is sensitive and specific for SLE-related 
neuropsychiatric manifestations. The assessment of individual patients is based on clinical, 
neurologic and rheumatologic evaluation, immunoserologic testing, brain imaging, and 
psychiatric and neuropsychological assessment. These examinations are used to support or 
refute the clinical diagnostic impression, rule out alternative explanations, and form the 
basis for prospective monitoring of clinical evolution and response to treatment 
interventions. The lack of a diagnostic gold standard makes the correct diagnosis of primary 
NPSLE a challenge. This realization has led us in developing under the auspices of the 
European League Against Rheumatology (EULAR) evidence and expert based 
recommendations for the management of NPSLE (Bertsias et al, 2010). 
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Magnetic resonance imaging (MRI) is the current modality of choice in the imaging 
assessment of NPSLE patients, due to its high sensitivity in detecting even small 
alterations in tissue water content (Sibbitt et al., 1999). However, the variable pathologic 
substrate of the NPLSE lesions result in low MRI specificity. Conventional MRI reveals 
lesions in about 50-75% of NPSLE patients, depending on the disease activity and the 
severity and kind of the neurological manifestations (focal or diffuse). In patients with 
focal symptoms conventional MRI commonly detects small, discrete, frontal–parietal 
subcortical or periventricular white matter lesions, hyperintense on T2 sequences,  that 
usually represent small acute or chronic infarcts, or even microhemorrhages. 
Unfortunately, these lesions are not specific for NPSLE and exhibit no clinical correlation. 
Additional intravenous Gadolinium administration is helpful in differentiating acute from 
chronic lesions. Mild-to-moderate cerebral atrophy could also be detected by T1 
sequences, associated with both generalized and focal brain injury.  
In NPSLE patients with diffuse neurological manifestations conventional neuroimaging 
usually fails to demonstrate abnormalities that explain these symptoms. Additionally, 
histopathological studies confirm the presence of extensive diffuse parenchymal and 
cerebrovascular injury that could not be identified by the conventional MRI techniques. On 
the contrary, brain tissue microscopic structural, hemodynamic or metabolic changes could 
be assessed by advanced, non-conventional quantitative neuroimaging techniques, such as 
Diffusion Weighted Imaging (DWI), Diffusion Tensor Imaging (DTI), Perfusion Weighted 
Imaging (PWI), Magnetization Transfer Imaging (MTI) and Magnetic Resonance 
Spectroscopy (MRS). Although not available in the current daily practice, these techniques 
are promising for the better understanding of the NSPLE, and improvement of the 
diagnostic work-up and treatment. 
We critically review the literature on brain imaging in NPSLE, with special emphasis on   
non-conventional neuroimaging techniques in order to access their contribution to 
diagnosis, understanding of the pathophysiology and clinical management. 
2. Histopathological changes in NPSLE 
The underlying pathologic basis of NP-SLE is still under investigation (Bertsias GK, 
Boumpas DT, 2010). Pathological studies revealed multiple microinfarcts,  noninflammatory 
thickening of small vessels with intimal proliferation, small-vessel occlusion, and 
intracranial embolism or hemorrhage (Van Dam et al., 1991). True vasculitis, with 
inflammatory infiltrate and fibrinoid necrosis is relatively rare, occurring in 6–9% of cases 
(Van Dam et al., 1991). Vasculopathy is most common. SLE vasculopathy affects 
predominantly arterioles and capillaries, resulting in vessel tortuosity, vascular 
hyalinization, endothelial proliferation, and perivascular inflammation or gliosis. This 
vasculopathy could be related to both acute inflammation and ischemia (Hanly et al., 1992; 
Van Dam et al., 1991).  
According to a recent histopathological study (Sibbit et al., 2010) the basic underlying 
pathologic process of NPSLE is cerebrovascular injury associated with disease activity and 
thromboembolism, resulting in focal and diffuse brain ischemia, small and large brain 
infarcts, focal and diffuse brain edema, brain hemorrhage, and focal and diffuse 
parenchymal injury. Multiple coexisting pathogenic mechanisms including, 
thromboembolism by cardiac valvular lesions, hypercoagulability, diffuse endothelial 
injury, and excitotoxicity could not be excluded (Roldan et al., 2006, 2008).  
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Four patterns of cerebrovascular disease NPSLE have been suggested: (1) an 
antiphospholipid  antibody cerebrovasculopathy characterized by bland thromboses, 
thrombotic microangiopathy, and arterial intimal fibrous hyperplasia; (2) a diffuse 
cerebrovasculopathy characterized by endothelial injury associated with increased SLE 
disease activity, glomerulonephritis, hypertension, and perhaps neuroexcitotoxic antibodies; 
(3) thromboembolic NPSLE directly caused by cardiac valvular lesions; and (4) mixed 
cerebrovascular NPSLE with simultaneous aspects of antiphospholipid- associated 
thrombosis, increased disease activity, and thromboembolic valvular lesions (Sibbit et 
al.,2010).  
3. Conventional MRI 
Conventional pre- and postcontrast-enhanced brain MRI appears normal in approximately 
one-third of both symptomatic and asymptomatic NPSLE patients (Chinn et al., 1997; 
Jennings et al., 2004). Hyperintense white matter lesions are revealed in up to 70% of SLE 
patients. In the majority of MRI studies in which white matter lesions were quantified, 
patient groups with NPSLE (active and inactive) showed a significantly higher number and 
total volume of white matter hyperintensities compared to non-NPSLE ( Appenzeller et al., 
2008; Castellino et al., 2008).  
According to a recent study (Luyendijk et al, 2011), that reviewed retrospectively the MRI 
exams of the first episode of active NPSLE in 74 patients,  4 types of findings were observed 
: 1) focal hyperintensities in white matter (49% of all patients and 84% of patients with 
abnormalities on MRI) or both white matter and gray matter (5%), suggestive of 
vasculopathy or vasculitis (Figure 1),  2) more widespread, confluent hyperintensities in the 
WM, suggestive of chronic hypoperfusion due to the same mechanisms, 3) diffuse cortical 
GM lesions (12%), compatible with an immune response to neuronal components or post-
seizure vasogenic edema, and 4) absence of MRI abnormalities, despite active signs and 
symptoms (42%). Small punctate focal white matter lesions, the most common imaging 
finding, are followed in prevalence by cortical atrophy, ventricular dilation and diffuse 
white matter changes. 
The small focal lesions- hyperintense on T2-weighted or FLAIR imaging- typically occur in 
periventricular and subcortical white matter, especially in the frontoparietal regions. They 
usually represent small resolved infarcts or focal areas of reduced neuronal density, but in 
some cases they may be the result of acute infarcts, focal edema, or even acute 
microhemorrhages (Sibbitt et al., 2010).The corresponding T1-weighted images often 
appearing normal (Ainiala et al, 2005), while FLAIR images have been shown to be more 
sensitive for detecting these lesions than T2 images. Periventricular lesions have been 
particularly associated with the antiphospholipid syndrome (APS) and can be impossible to 
differentiate on MRI from multiple sclerosis (Peterson et al., 2005). 
Although the focal hyperintense white matter lesions are often considered nonspecific-
since they are indistinguishable from age-related small vessel disease -they may occur 
much earlier and in greater numbers in SLE subjects. These findings also seem to be more 
common in patients with NP-SLE in the presence of antiphospholipid antibodies, 
although no clinical correlation was observed in most studies (Ainiala et al., 2005). In a 
large prospective population-based study involving healthy individuals, the presence of 
focal hyperintense white matter lesions was associated with cognitive impairment 
(Vermeer et al., 2003). In addition, correlations have been observed between white matter 
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hyperintensities and both cumulative SLE related injury scores, including 
neuropsychiatric damage (SLICC/ACRDI), and separate neuropsychiatric component 
scores of SLE-injury indices (neuro-SLEDAI and neuro-SLICC) (Appenzeller et al., 2008;  
Ainiala et al., 2005). 
 
 
Fig. 1. FLAIR and T1 MR images of a 44 years female with NPSLE reveal multiple focal 
punctuate lesions-hyperintense on FLAIR and hypointense or isointense on T1- at the 
periventricular and subcortical white matter, semioval center and the cortex of the left 
frontal lobe.  
Besides aging, white mater hyperintensities are also associated with hypertension, valvular 
heart disease, and migraine, conditions that commonly occur secondary or concomitantly to 
NPSLE. Consequently, it is not possible to differentiate NPSLE from other vasculopathies 
using conventional MRI. The differentiation of acute active disease from old chronic lesions 
is also difficult. It has been noted that the presence of indiscrete lesion borders, intermediate 
intensity of T2 lesions and grey matter lesions are all indicative of active disease (Sibbitt et 
al., 1999). The use of gadolinium has also been shown to be helpful in delineating active 
inflammatory lesions that usually enhance (Miller et al., 1992). Quantitation of T2 values has 
also been shown to be helpful in distinguishing active from chronic lesions (Sibbitt et al., 
1995). T2 values appear to be increased in the normal appearing frontal grey matter of 
patients with active diffuse neurological syndromes. 
MRI studies may show extensive bilateral, potentially reversible, white matter 
abnormalities in the cerebral hemispheres, the brainstem, or the cerebellum usually 
associated with active NPSLE—the so-called “acute posterior leukoencephalopathy,”( 
Sibbitt et al., 1999). The reversible lesions of acute leukoencephalopathy of NPSLE have 
been attributed to focal cerebral edema associated with blood vessel injury and 
microhemorrhages (Sibbitt et al, 2010). 
Atrophy was described in 6–12% of SLE patients (Appenzeller et al., 2005,2008) and is 
associated with multiple factors such as disease duration (Cauli et al., 1994), corticosteroid 
use (Appenzeller et al., 2005; Ainiala et al, 2005), older age (Appenzeller et al, 2005), 
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antiphospholipid antibodies (Appenzeller et al., 2008; Provenzale et al., 1996) and the 
presence of hyperintense white matter lesions (Appenzeller et al., 2005; Chinn et al., 1997). 
The loss of tissue within the brain is thought to result from a combination of both myelin 
damage and axonal loss, followed by Wallerian degeneration, and the loss of extracellular 
space and vascular compartments. The histopathological findings associated with MRI-
visible cerebral atrophy were highly variable and included multiple infarcts and reduced 
neuronal density, suggesting that atrophy in NPSLE may be associated with both 
generalized and focal brain injury. However, normal histological appearance was also noted 
in some atrophic brains (Sibbitt et al., 2010). 
Cerebral atrophy is usually measured from T1-weighted MRI scans, where good contrast 
between the cerebral spinal fluid (CSF) and the brain parenchyma is observed (Appenzeller 
et al., 2008). Because high spatial resolution images allow brain volume measurement with 
the greatest accuracy and precision, three-dimensional gradient methods are generally 
preferred. As cerebral atrophy can be measured serially on MRI scans of the brain by linear 
or volumetric measurements, it has been proposed as a means of monitoring the progression 
of SLE (Appenzeller et al., 2005, 2008).  
Regional atrophy in SLE patients has also been described involving cortical and 
subcortical regions, with particular clinical significance. Selective involvement of the 
amygdala in patients with SLE and anti-NMDAR antibodies has been found (Emmer et 
al., 2006). Cognitive impairment may be present more frequently in both corpus callosum 
and hippocampal atrophy (Appenzeller et al., 2006, 2008). Mild or clinically insignificant 
spinal cord pathology has also been described in SLE, which might be secondary to 
Wallerian degeneration of long tract fibers passing through damaged areas of the brain 
(Benedetti et al., 2007). 
MR Angiography detects medium-to-large vessels involvement. Since a small vessel 
vasculopathy represents the major histopathological background of brain involvement in 
NPSLE angiographic techniques are usually negative, although angiographic arterial 
stenoses or occlusions are rarely reported (Weiner et al., 1991). Multiple mechanisms for 
angiographic arterial stenosis or occlusion have been considered, including coagulopathy, 
cardiogenic embolism, atherosclerosis from long-term steroid use and anticoagulant or 
antiplatelet therapy, vasculitis due to SLE or infection, or a combination of these processes 
(Devinsky et al., 1998). 
Conventional MRI techniques are particularly useful in NPSLE patients with acute focal 
neurologic deficits, although they cannot always differentiate lesions indicating active 
acute NPSLE from chronic lesions that represent past NPSLE. The differential diagnosis 
usually includes thromboembolic events due to vasculopathy, lupus-related CNS 
vasculitis, antiphospholipid antibodies (APL-Ab)- mediated thrombosis, microangiopathy 
(including thrombotic thrombocytopenic purpura), Libman-Sacks endocarditis, and 
accelerated atherosclerosis. The pathogenesis in many patients is probably multifactorial. 
Accurate assessment is crucial, as treatment for these alternative diagnoses differs. 
Immunosuppressive agents are typically used for suspected vasculitis, while lifelong 
anticoagulation is the mainstay of therapy for APL-Ab-mediated thromboembolic  
events.  
In diffuse NPSLE presentation conventional MRI could be unremarkable since it doesn’t 
give information about damage in normal-appearing tissue (Sibbitt et al., 1999). Non-
conventional MRI techniques, sensitive to microstructural, hemodynamic and biochemical 
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characteristics of the tissues have been developed, that could detect gray and white matter 
abnormalities in NPSLE patients, otherwise occult by conventional imaging. 
4. Advanced MRI methods 
4.1 Diffusion–weighted imaging 
Diffusion-weighted imaging (DWI) is a magnetic resonance technique that is based on the 
random, incoherent (brownian) motion of protons on the molecular scale. In free water, 
proton-containing molecules move unrestricted in all directions, a situation that is referred 
to as isotropy. In highly structured tissue, such as the corticospinal tract, molecules 
encounter fewer barriers when moving in a craniocaudal direction than in directions 
perpendicular to it. This situation gives rise to preferential molecular movement in a certain 
direction, which is known as anisotropy. DWI can be used to measure diffusivity in the 
brain, providing signal proportional to the molecular diffusion of water molecules (Schaefer 
et al., 2000).  
Diffusion Tensor Imaging (DTI) is a DWI technique that permits assessment of the 
preferential direction of proton diffusivity (Ulug et al., 1999). DTI offers increased resolution 
compared to conventional MRI regarding white matter microstructure by measurement of 
water diffusion through cellular compartments in vivo (Pierpaoli et al., 1996). Compared to 
more isotropic movement of water in gray matter, water diffusion in white matter moves 
anisotropically, meaning that water diffuses preferentially along the length of the axon 
compared to perpendicular to the axon. This anisotropic diffusion of water appears to be 
due to the highly structured axonal membranes and their associated myelin sheaths (Cascio 
et al., 2007). By tracking the diffusion of water in the brain, the measure fractional 
anisotropy (FA) and mean diffusivity (MD) can be derived. Higher FA (and lower MD) 
suggests greater axonal coherence and myelination. Measures of FA are usually considered 
to be overall measures of axonal integrity, reflecting either increased axonal caliber, 
increased myelin thickness, increased fiber coherence in a given direction, or some 
combination of these factors. In contrast, MD, is a measure of the average molecular motion 
independent of the constraints of tissue boundaries, and is affected by cellular size and 
degradations in tissue integrity (Pierpaoli et al., 1996). One way to assess the magnitude of 
diffusion is by calculating the apparent diffusion coefficient (ADC), an index of mean 
diffusivity, for individual pixels on average apparent diffusion coefficient (ADC) maps. 
Average diffusion coefficient (ADC) maps provide information on the microstructure of 
tissue and can be very useful in the detection of disease ADC values that can be assessed 
locally in regions of interest (ROIs). Another way is the generation of ADC histograms for 
the whole brain (Nusbaum et al., 2000). Such measures consisted of mean ADC values of the 
whole brain volume and descriptive parameters of ADC histograms of the whole brain, such 
as peak height. Relatively few studies have emerged showing water diffusivity changes in 
NPSLE. DWI was first used by Moritani and co-workers (Moritani et al., 2001) who detected 
acute or subacute lesions in 9 of 20 patients with SLE (45%). Two main patterns of acute or 
subacute brain parenchymal lesions were described. The first include hyperintense lesions 
with decreased ADC indicating acute or subacute infarction due to primary or secondary 
arterial stenosis or occlusion (Figure 2) and the second isointense or slightly hyperintense 
lesions on diffusion-weighted images with increased ADC representing vasogenic edema, 
with or without microinfarcts, due to small-vessel vasculopathy or hypertensive 
encephalopathy (Figure 3). 
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Fig. 2. Hyperintense lesion at the right corona radiata with increased signal intensity on 
DWI and decreased signal intensity on ADC map due to acute infarction. 
 
 
Fig. 3. Hyperintense lesion at the right semioval center with increased signal intensity on 
DWI and increased signal intensity on ADC map, due to vasogenic edema. 
DWI then was used in NPSLE patients to provide quantitative measures of the integrity of 
the entire brain (Bosma et al., 2003). Using ADC histograms of the whole brain, in a group of 
11 patients with a history of non focal NPSLE and 10 healthy volunteers they found changes 
in NPSLE patients who had no relevant changes on conventional MRI,   that correlated with 
their clinical symptoms. The ADC histograms of the NPSLE group were, on average, 
significantly lower and broader, with a significant decrease of the peak height and a 
significant increase in the number of pixels with higher ADC values compared to the 
healthy subjects. The flatter and broader histograms in the NPSLE group indicate that, in 
these patients, widespread increased motility of free-water protons occurs. The subtle white 
matter hyperintensities that were visible on conventional MR images seemed unlikely to be 
responsible for the significantly different diffusion pattern in NPSLE because their number 
and sizes were small. These findings suggest that widespread damage exists in the brain 
parenchyma of NPSLE patients, invisible with conventional MRI. However, the method 
used in that study did not permit assessment of which parts of the brain were responsible 
for the observed changes in the ADC histograms of the whole brain.  
Welsch and co-workers investigated 21 acute NPSLE patients and 21 healthy volunteers 
using also ADC histograms (Welsch et al., 2007).Whole-brain histograms, gray matter only 
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histograms, and white matter only histograms were calculated for each subject. They found 
increased mean ADC values in acute NPSLE, not only in the whole-brain histograms, but 
also in the gray matter only  and white matter only, indicating that the cerebral alterations is 
not limited to one tissue compartment.  
Zhang and co-workers used a region of interest (ROI) approach for ADC and FA 
measurements to assess a cohort of 34 patients diagnosed with SLE, and 29 healthy 
volunteers  (Zhang et al., 2007). They found early diffusion changes (higher diffusion values 
and lower FA values) in the frontal lobe, the genu of the corpus callosum, and the anterior 
internal capsule in patients with SLE, although routine MRI findings were negative. 
Another group (Hughes et al., 2007) compared 8 female NPSLE patients, with new onset of 
symptoms, to 20 healthy controls using diffusion tensor imaging (DTI) and an ROI 
approach. They found that these patients differed from controls in a wide range of normal 
appearing gray and white matter regions including the insular cortex, thalamus, parietal 
and frontal white matter, and corpus callosum. These findings are suggestive of the 
presence of subtle and widespread damage in the brain parenchyma in NPSLE patients. 
Recently Jung and co-workers  (Jung et al., 2010) using DTI and the tract-based spatial 
statistics (TBSS) analysis  technique  assessed  white matter abnormalities in 17 NPSLE 
patients, 16 SLE patients without NPSLE, and 20 age- and gender-matched controls. 
According to their findings there were no significant FA or MD differences observed 
between the SLE patients without NPSLE and the matched controls, although many of the 
SLE patients had subcortical white matter and periventricular lesions. In contrast, when 
comparing the acute NPSLE patients to controls, or the acute NPSLE patients to patients 
with SLE without NPSLE they found decreased   FA and   increased MD values especially at 
the corpus callosum and the left anterior corona radiata reflecting diffuse white matter 
abnormalities. They suggest that either the acute effects of the NPSLE disease, or its 
treatment, results in white matter changes discernable with conventional MRI techniques. 
This study provides new evidence that FA and MD may have diagnostic use in NPSLE by 
demonstrating, for the first time, regional brain specificity, and by distinguishing NPSLE 
from SLE patients, further indicating the potential diagnostic specificity of this technique for 
patients in the acute stage of this difficult disease. 
Using the same analysis technique Emmer and co-workers  (Emmer et al., 2010) investigated 
12 patients with SLE (7 with NPSLE) and 28 healthy controls with DTI and found reduction 
in the FA values of patients with SLE as compared with normal subjects, indicating reduced 
integrity at particular white matter tracts. The integrity of the subcortical white matter tracts 
of the occipital, parietal and posterior frontal lobe was relatively preserved, whereas the 
frontobasal and temporal regions including the inferior fronto-occipital fasciculus, the 
fasciculus uncinatus, as well as the fornix, the posterior limb of the internal capsule 
(corticospinal tract), and the anterior limb of the internal capsule (anterior thalamic 
radiation) seem to be predominantly involved. 
The increased ADC values, as well as the decreased FA values, could be explained by 
reduced structural integrity of the brain parenchyma with permanent loss of neurons and 
demyelination in patients with NPSLE. This will allow the interstitial water molecules to 
move freely in a less restricted environment. Normally, the ADC values decrease and the FA 
values increase by the restriction of motion in a particular direction, for example, due to the 
boundaries of myelin sheets. Alternatively, loss of structural brain integrity would allow 
interstitial water molecules to move in a more unrestricted environment, thus resulting in an 
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increase in ADC and decrease in FA. A breakdown of the myelin sheets, as in 
demyelination, would result in less restricted movement of the water molecules transverse 
to the fiber tracts. The observed increase in gray matter ADC can be interpreted as 
consistent with inflammation and/or vasculitis of the gray matter.  
It has been suggested that the abnormal diffusion findings seen in the brain of NPSLE 
patients are not mainly related to hypoxic/anaerobic events, but, rather, indicate a host 
response to injury, such as an inflammatory reaction, membrane activation, or 
demyelination (Sibbitt et al., 1997). Such a theory can be supported by histopathology 
studies in which gliosis and demyelination has been described in the brain parenchyma of 
patients with NPSLE (Hanly et al., 1992). Immune-mediated vascular or neuronal injury was 
postulated and subsequent neuronal and metabolic dysfunction resulting in edematous 
processes that increase water content in WM regions of the brain. 
The white matter damage in NPSLE could be the indirect result of subtle noxious influences 
in NPSLE, such as repeated episodes of acute inflammation in small vessels. This could 
cause priming or activation of the wall of these small vessels by complement and/or 
antiendothelial antibodies. Priming or activation of the vessel wall could subsequently lead 
to vasculopathy and microinfarcts or subtle hypoperfusion in the small vessels of the brain 
(Zvaifler et al., 1982). Altered cerebral blood flow was previously demonstrated with PET 
and SPECT in NPSLE patients (Kuschner et al., 1990; Kao et al., 1999). If hypoperfusion 
occurs, it might be responsible for the metabolic abnormalities reported in NPSLE patients, 
as suggested by decreased high energy phosphate levels in phosporus-31 MR spectroscopic 
studies and decreased brain oxygen consumption in PET studies. The end stage of this 
process might be axonal loss and associated demyelination. It is also possible that antibodies 
aimed directly against myelin, leading to direct white matter damage through a pervasive 
attack on axonal myelin sheaths or the oligodendrocytes from which they are derived. The 
involvement of the white matter could be, finally, the reflection of axonal damage through 
Wallerian degeneration caused by damage to the gray matter (Emmer et al., 2010). 
Diffusion differences affecting acute NPSLE patients could also be related to therapy, 
whereby the introduction of corticosteroids, or other immunosuppression drugs (i.e. 
cyclophosphamide), and/or disease modifying antirheumatic drugs, can affect water 
content in the brain parenchyma. Another possible mechanism may be related to platelet or 
fibrin macro- or microembolism from Libman-Sacks endocarditis or anticardiolipin 
antibodies causing multiple areas of macroscopic or microscopic ischemia, infarctions, and 
microhemorrhages with surrounding edema (Roldan et al., 2006).  
Undoubtedly, one of the more useful applications of DWI in clinical practice is the 
assessment of cerebro-vascular accidents; in these conditions DWI allows early detection 
(within 1 h) of acute ischemic insult showing a reduction of ADC due to cytotoxic edema 
which occurs rapidly after the onset of ischemia (Figure 2). DWI also permits to discriminate 
between recent (with restricted diffusivity) and old (with normal diffusivity) hyperintense 
ischemic lesions which can be otherwise undistinguishable with conventional MRI. 
Furthermore, for its ability to differentiate between vasogenic and cytotoxic edema, DWI 
could be also useful in SLE patients to discriminate between inflammatory and ischemic 
lesions (Iguchi et al., 2007). Increased diffusion occurs although conventional MRI findings 
are negative in some cases, which suggests that DTI is more sensitive and that quantitative 
diffusion measurements can be used in detecting early signs of SLE or, furthermore, 
monitoring disease evaluations. The findings of diffusion-weighted imaging may help guide 
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the choice of treatment and predict patient outcome in patients with SLE and CNS 
involvement. 
4.2 Perfusion weighted imaging 
A variety of imaging techniques have been used to assess cerebral perfusion, beginning with 
positron emission tomography (PET). PET is a nuclear medicine technique which explores 
both brain glucose metabolism and cerebral blood flow (CBF). In patients with NPSLE 
multiple areas of hypometabolism were detected in both MRI normal-appearing white and 
grey matter regions (Otte et al., 1997). Although PET has high sensitivity (abnormal in 100% 
of patients with active NPSLE), it lacks specificity and due to its high radiation dose, high 
cost and  limited availability, is  rarely applied in the  daily clinical practice. 
Over the past two decades, two more perfusion imaging techniques, single photon 
emission computed tomography (SPECT), and perfusion-weighted MRI (PWI), were 
introduced. These techniques have been used to evaluate a variety of disease states, most 
commonly acute and chronic ischemia. SPECT is based on the radio-tracer uptake by 
viable neuronal cells and explores brain perfusion that is the result of both CBF and 
neuronal integrity. The most commonly observed abnormalities detected by SPECT in 
patients with NPSLE are diffuse, focal or multifocal areas of decreased uptake 
corresponding to hypoperfusion, which -according to some authors- correlates with NP 
disease severity and activity (Colamussi et al., 1995). Other SPECT studies reported CBF 
abnormalities in NPSLE without correlation to disease activity or serological parameters. 
There is also no significant associations between perfusion parameters and NP symptoms 
(Waterloo et al., 2001). A recent voxel-based SPECT study found no difference in 
perfusion parameters between healthy controls and SLE patients with inactive NP 
involvement. However the authors found a global hypoperfusion in active NPSLE 
patients compared to healthy controls, which was mainly located in the cortical gray 
matter (Appenzeller et al, 2008). Although SPECT has high sensitivity (abnormal in 86–
100% of patients with major NPSLE) it lacks specificity (abnormal in 10–50% of SLE 
patients without NPSLE) and has limited anatomic resolution. 
The most commonly used MR perfusion technique is dynamic susceptibility contrast (DSC) 
imaging. This is a non-invasive dynamic process based on the MR signal changes during the 
first pass of the intravenously injected contrast agent (a gadolinium chelate) through the 
vasculature. The change in signal intensity is then measured and perfusion maps are 
generated, most commonly encountering cerebral blood volume (CBV), cerebral blood flow 
(CBF), time to peak (TTP), or mean transit time (MTT)values. Nowadays PWI is widely used 
in the acute stroke, for evaluation of the salvageable tissue and the brain neoplasms to detect 
neoangiogenesis. This technique could be useful in NPSLE and antiphospholipid syndrome 
(APS) patients (Figure 4) at risk of cerebro-vascular ischemic events, but reports on the use 
of PWI in NPSLE are still very few and limited.  
The first multimodality approach in patients with SLE was performed by Borelli and co-
workers (Borelli et al., 2003) using simultaneously MRI, DWI, PWI and SPECT in 20 SLE 
patients. They found that SPECT was more sensitive than PWI in detecting brain 
hypoperfused areas, probably due to the different aspects of brain perfusion explored by 
these two techniques. PWI is a dynamic process related to the blood supply to the 
anatomical districts of the brain, while  SPECT images reflect the distribution of a flow tracer 
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whose uptake at the neuronal level may, however, be in part influenced by the metabolic 
status of the nervous tissue. Therefore the combination of these techniques might yield more 
information about the underlying pathogenetic mechanism of brain hypoperfusion.  
 
 
Fig. 4. Imaging of an acute ischemic lesion in a 45 yrs old female with NPSLE and 
antiphospholipid syndrome (APS), 4 hours after the onset of the symptoms. FLAIR is 
unremarkable, while the lesion is revealed on DWI and ADC map as hyperintense and 
hypointense area, respectively, due to cytotoxic edema. Dynamic Susceptibility Contrast 
(DSC) MR Perfusion technique shows mild increased cerebral blood volume ( red on CBV 
map), decreased cerebral blood flow (dark blue on CBF map) and increased  mean transit 
time (red on MTT map)  
Two recent studies with application of dynamic susceptibility contrast perfusion MRI in SLE 
patients have opposite results. In the first study 15 active NPSLE, 26 inactive NPSLE and 11 
control subjects were investigated and no signs of focal or global abnormalities in the 
perfusion parameters of the patients were found (Emmer et al., 2010). Furthermore, no 
significant differences were found when comparing patients with a specific SLE criterion 
(lupus anti-coagulant LAC, anti-cardiolipin antibodies or APS).The main limitation of this 
study is the fact that the CBF and CBV values have been calibrated to normal white matter, 
assuming that perfusion in the contralateral white matter is normal. This assumption could 
be erroneous in SLE patients with diffuse NP symptoms, like cognitive dysfunction or 
headache. 
In the second study (Gasparovic et al., 2010)the DSCMRI technique was performed in 42 
SLE patients and 19 healthy controls. They demonstrated higher CBV and CBF throughout 
cortical and white matter regions in the SLE patients (with or without lesions) relative to the 
control group. According to the authors the higher global CBF and CBV values may be due 
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to reactive physiologic or pathogenic factors underlying SLE, such as vasomotor instability, 
compensatory mechanisms for resolving injury, low-grade excitotoxicity due to antibody 
impairment of N-methyl D-aspartate (NMDA) receptors, or inflammatory factors. This 
global hyperperfusion in SEL patients is in contrast with most SPECT studies that reveal 
patchy hypoperfused areas in SLE patients. More studies should be performed to SLE and 
NPSLE patients with application of both SPECT and MRI perfusion techniques to further 
delineate this issue.  
4.3 Magnetization Transfer Imaging (MTI) 
MTI is a quantitative MRI technique that is sensitive to macroscopic and microscopic brain 
tissue changes (Grossman et al., 1994; Wolff et al., 1994) and more sensitive to the presence 
of disease than conventional MRI. In MRI, the magnetic characteristics of free-water protons 
determine the contrasts of the images. MTI is based on the magnetization transfer that 
occurs between the bound pool of macromolecule-related protons in biologic tissues and the 
pool of free water protons. In MTI, a saturating RF pulse selectively reduces the 
magnetization of the bound pool. Due to the interactions between the two proton pools, the 
magnetization of the free-water pool is also reduced, which is called the MT effect. Tissue 
factors that affect the amount of this magnetization transfer are the concentration of 
macromolecules and the surface chemistry and biophysical dynamics of the macromolecules 
(Wollf et al., 1994). Macromolecules that contribute to the MT effect in the brain are the 
cholesterol component of myelin, cerebrosides, and phospholipids (Koenig et al., 2001).  
The amount of MT is expressed by the magnetization transfer ratio (MTR) value. MTR 
values can be easily calculated in regions of interest (ROIs) to assess local tissue 
composition. In most diseases affecting the brain, MTR values are reduced, presumably due 
to dilution or destruction of macromolecules (Finelli et al., 1998). Using this approach it has 
been proved that MTI could detect abnormalities in brain tissue that are not visible in 
conventional MRI in cases of multiple sclerosis (Rovaris et al., 2000).Whole brain assessment 
can be also performed using MTR histograms for quantification of the disease burden of the 
whole brain (van Buchem et al., 1997). According to this volumetric method, the intracranial 
volume (ICV) is segmented, and the MTR values of the segmented brain are displayed as a 
histogram. Gray and white matter have different mean MTRs, which is probably mainly due 
to different concentrations of myelin. Still, the histograms for gray matter and white matter 
overlap substantially. The summation of these 2 histograms results in a histogram that is 
characteristic of the whole brain. The shape of this whole-brain histogram reflects conditions 
that affect the gray and white matter. MTR histograms of normal brains are characterized by 
the presence of a single, sharp peak, indicating that most normal brain voxels have 
approximately the same MTR values due to relative homogeneous tissue composition and 
microstructure. Demyelination, edema, atrophy and gliosis could impair MTR and the MTR 
histograms shape become flattened with decreased peak height reflecting dyshomogeneity 
of the brain tissue. In this way MTI allows the evaluation of brain tissue integridy, while 
simultaneously permits quantification of structural damage.  
Studies that compared MS patients with normal controls using MTI revealed that the MTR 
histogram peak height was the volumetric MTI parameter that differed most significantly 
(van Buchem et al., 1998). This peak height was found to be decreased in MS patients.  It was 
suggested that the peak height was a measure of the amount of residual normal brain tissue, 
and therefore inversely reflected the disease burden of the brain (van Buchem et al., 1998). In 
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several MS studies, this measure was found also to correlate with measures of cognitive and 
neurologic functioning (van Buchem et al., 1998). 
MTI has been applied in NPSLE patients without visible abnormalities on conventional 
MRI. All these studies used MTR histograms for the quantitative assessment of the whole 
brain abnormalities. Bosma and co-workers (Bosma et al., 2000) applied the MTI technique 
to 11 patients with NPSLE, 11 patients with SLE without history of NPSLE (non-NPSLE) 
and 10 healthy volunteers. In this study, for every patient, an MTR histogram was created 
after correction for the ICV and another was created after correction for brain volume. In 
MTR histograms that are adjusted for the ICV, the peak height reflects both the integrity 
of brain parenchyma and the extent of atrophy. A different distribution of the brain 
voxels, in terms of changes in MTR values due to disorders of brain parenchyma or a 
reduction in the total number of brain voxels due to atrophy, can cause a decrease in the 
peak height. The peak height of the MTR histograms corrected for brain volume is 
affected only by the aspect of brain parenchyma, and not by the volume of the brain and 
atrophy (van Buchem et al., 1998). In the group of NPSLE patients, the average peak 
height of the histograms corrected for intracranial volume and the peak height 
normalized for brain volume were significantly lower than in either the non-NPSLE 
patients or the healthy controls at the same position of the peaks. This suggests the 
presence, in NPSLE, not only of atrophy, but also of an abnormality of the remaining 
brain parenchyma. The latter disorder in NPSLE is probably primarily present in the 
normal appearing parenchyma, since the low number and small size of hyperintense 
lesions observed in these patients cannot solely account for the decreased peak height of 
the histograms. Since myelin is a major contributing factor to the MT effect in the brain, 
the decreased peak heights of the MTR histogram corrected for brain volume might have 
originated from demyelination along with axonal loss. Edema and gliosis are also 
considered to give rise to abnormal MTRs (Dousset et al., 1992). 
In another study (Bosma et al., 2000) MTI was performed to 9 patients with active 
nonthromboembolic NPSLE, 10 patients with chronic NPSLE, 10 patients with SLE and no 
history of NPSLE (non-NPSLE), 10 patients with inactive MS, and 10 healthy control 
subjects, to investigate whether volumetric MTI analysis with MTR histograms can 
demonstrate abnormalities in patients in the acute stage of diffuse NPSLE and compare 
these findings with those from chronic SLE, non-SLE and MS. The MTR histograms of both 
the non-NPSLE group and the healthy controls were similar. There was flattening of the 
histograms in the active NPSLE group, but with a shift toward higher MTRs. These changes 
indicate that the uniformity of the brain in patients with active NPSLE is lower than that in 
SLE patients with no history of NPSLE as well as that in healthy controls, suggesting that 
patients with active NPSLE can be distinguished from SLE patients with no history of 
NPSLE by use of MTR histogram analysis. The shift of the MTR histogram peak to the right 
that was observed in active NPSLE suggest an all-over improvement in the exchange of 
saturation from the pool of bound protons to that of the free water protons. Increased MTRs 
were also found in an experimental model of acute inflammation in MS, experimental 
allergic encephalomyelitis, during the early phase of inflammation in that disease (Dousset 
et al., 1992). Similar processes may occur during the active phase of NPSLE. In this study, all 
MTR histogram parameters in chronic NPSLE and MS were identical. Since NPSLE and MS 
are diseases with a different biologic behavior, it is unlikely that these similarities suggest a 
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similar pathogenesis. Instead, the similarities indicate that different diseases may give rise to 
a common final pathway (i.e., gliosis and demyelination) that results in similar changes in 
the MTR. These results also demonstrate that in the chronic stage of diffuse brain diseases, 
MTR histograms may not be able to differentiate between different diseases.  
The same group (Bosma et al., 2002) further investigated the relationship between 
quantitative estimates of global brain damage based on magnetization transfer imaging 
(MTI) and the cerebral functioning, as measured by neurologic, psychiatric, and cognitive 
assessments, as well as the disease duration in patients with NPSLE. They performed MTI to 
24 patients with NPSLE and found significant correlations between the descriptive measures 
of the MTR histograms and: a) the neurologic functioning quantified by the Kurtzke’s 
Expanded Disability Status Scale (EDSS) b) the cognitive functions with the Wechsler Adult 
Intelligence Scale Revised (WAIS-R), a standardized psychometric test for assessing  
intelligence and c) the  psychiatric functioning by the Hospital Anxiety and Depression 
Scale (HADS) questionnaire. Since the EDSS score mainly assesses motor skills, these 
findings suggest that atrophy and diffuse microscopic damage of the remaining brain 
parenchyma in NPSLE affect, among other areas, brain regions that are responsible for 
motor skills. Atrophy and diffuse microscopic cerebral damage also contribute the 
development of psychiatric symptoms, like anxiety and depression and cognitive 
impairment. There is no correlation between the quantitative estimates of global brain 
damage and age, SLE duration, or time elapsed since the first occurrence of 
neuropsychiatric symptoms suggesting that the accumulation of brain damage over time 
has a nonlinear aspect. 
Dehmeshki and co-workers (Dehmeshki et al., 2002) developed an alternative way of 
analyzing and globally characterizing MTR histograms by using multivariate discriminant 
analysis (MDA) and correctly assigned patients with MS to clinical subgroups. The same 
group proceed to a study in SLE patients in order to explore the diagnostic potential of 
MDA for assigning patients with SLE to different subgroups of patients with on the basis of 
MTR histograms (Dehmeshki et al., 2002). MTI was performed to 9 patients with active 
NPSLE, 10 patients with chronic NPSLE, 10 patients with SLE and no history of NPSLE 
(non-NPSLE), 10 patients with inactive MS, and 10 healthy control subjects. Three binary 
comparisons were made: First, comparison of active NPSLE versus past NPSLE groups 
which is important because in patients with NPSLE, a new episode of neuropsychiatric 
symptoms could be due to an active intrinsic SLE-related brain process—that is, a recurrent 
active phase of NPSLE—or to extrinsic processes such as the side effects of drug use. 
Secondly,  comparison of active NPSLE from non-NPSLE which is also important because 
an acute episode of neuropsychiatric symptoms could be due to active NPSLE or to extrinsic 
processes in patients with SLE. Finally, comparison of patients with active and/or past 
NPSLE with those who have MS which important because in patients who present with 
neuropsychiatric symptoms, the differential diagnosis includes SLE and MS, and these 
diseases are notoriously difficult to differentiate. In this study, MDA proved to be effective 
in assigning the majority of individual patients to disease categories in the given binary 
comparisons. In addition, MDA was shown to be considerably more effective for 
categorizing patient groups on the basis of MTR histograms than the conventional method 
of analyzing MTR histograms and might be of help in clinical practice. 
Steens and co-workers (Steens et al., 2004) performed MTI in 24 SLE patients with a history 
of diffuse neuropsychiatric symptoms and 24 healthy controls to assess the distribution of 
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MTI abnormalities over gray matter (GM) and white matter (WM) in SLE patients without 
explanatory MRI evidence of focal disease. MTR maps were calculated for GM and WM 
separately, and GM and WM MTR histograms were generated. Significantly lower peak 
height and mean MTR of the gray matter were found in NPSLE patients as compared with 
healthy controls indicative of parenchymal brain damage specifically in the GM in SLE 
patients with a history of NP symptoms and without explanatory focal abnormalities seen 
on MRI.  This observation supports the model of neuronal damage in diffuse NPSLE, and 
can be explained by the greater susceptibility of GM to the sequelae of small-vessel disease 
and hypoperfusion. Small-vessel disease itself may also increase blood–brain barrier 
permeability, which facilitates the entrance of antineuronal antibodies. In either case, 
because of the higher concentration of neurons in GM, the GM will be particularly affected. 
The same group (Steens et al., 2006) examined the correlation between gray and white 
matter magnetization transfer ratio (MTR) parameters and the presence of IgM and IgG 
anticardiolipins antibodies (aCLs) and lupus anticoagulant in 18 patients with NPSLE, but 
without cerebral infarcts on conventional magnetic resonance imaging. Lower gray and 
white matter mean MTR and peak location were observed in IgM aCL-positive patients than 
in IgM aCL-negative patients. No significant differences were found in MTR histogram 
parameters with respect to IgG aCL and lupus anticoagulant status, nor with respect to anti-
dsDNA or anti- ENA (extractable nuclear antigen) status. 
Various autoantibodies have been implicated in the pathogenesis of NPSLE, including 
anticardiolipin antibodies (aCLs) .Because of their prothrombotic tendency, aCLs may cause 
cerebral infarctions and as such they are correlated with focal neurological syndromes 
(Denburg, Denburg, 2003). In a study of Steens and co-workers (Steens et al., 2006) MTI 
parameters demonstrated brain damage in aCL-positive SLE patients in the absence of 
cerebral infarcts on conventional MRI. These findings suggest that, apart from giving rise to 
macroscopic cerebral infarctions, aCLs may play a role in the pathogenesis of diffuse 
microscopic brain damage in NPSLE. According to the authors there are at least three 
possible explanations for how aCLs could be involved to diffuse microscopic brain damage 
in NPSLE. First, the thrombotic tendency of antiphospholipid antibodies, including aCLs, 
may cause aggregation of thrombocytes and an increase in blood viscosity (Scolding, Joseph 
2002; Connor, Hunt 2003). This may affect blood flow in small cerebral blood vessels in 
particular and cause widespread hypoperfusion, which subsequently causes ischaemic 
damage to brain tissue. Second, aCLs may activate endothelial cells and cause a diffuse 
small-vessel vasculopathy – a neuropathological finding that was reported as long ago as 
1968 (Connor, Hunt 2003; Scolding, Joseph 2002). The resulting increase in blood–brain 
barrier permeability permits entrance to the brain parenchyma of substances such as 
circulating antibodies. Third, it has been shown in vitro that IgG aCLs themselves may 
interfere with glutamatergic pathways by a mechanism involving over-activation of the N-
methyl-d-aspartate receptor (Andreasi et al., 2001). 
Emmer and co-workers (Emmer et al., 2006) proved that changes in the clinical status of 
individual NPSLE patients correspond to changes in the MTR peak height and MTI is a 
valuable objective measure for following a clinical course in NPSLE. 19 active or inactive 
NPSLE patients underwent MTI on at least two separate occasions. Their neuropsychiatric 
status between the first and the second MRI sessions was classified as deteriorated, stable, or 
improved. In all clinically deteriorated patients the MTR peak height decreased between the 
first and second scans. In all clinically improved patients the MTR peak height increased 
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between the first and second scans, indicating that brain involvement in NPSLE patients, as 
detected by MTI, is at least partly reversible. The nature of the pathophysiological substrate 
of the reversible MTR changes in NPSLE patients is unclear. According to the authors 
reversible changes in the integrity of the parenchyma are probably due to edema, since 
neuronal loss would not show such a degree of reversibility, and neuronal apoptosis is not a 
common finding in postmortem studies of NPSLE. Inflammation influences the vessel walls 
and permits extravasation of fluid and inflammatory mediators into the brain tissue that 
leads to inflammatory brain edema 
4.4 Magnetic Resonance Spectroscopy 
Proton Magnetic Resonance Spectroscopy (MRS) is an MRI technique that permits study of 
the metabolites in tissue and provides qualitative and quantitative information about some 
brain metabolites displayed as spectra. The position of metabolites peaks in the spectrum is 
determined by its molecular characteristics. Studies in humans have used hydrogen –MRS 
(H-MRS) and rarely phosphorous-MRS (P-MRS). In normal water-suppressed, localized H-
MRS of human brain at echo times (TEs) between 135 msec and 270 msec 3 major 
neurometabolites are revealed: 1. N-acetylaspartate (NAA) with peak at 2.0 parts per 
million, which can be used as a neuronal marker, because  is found exclusively in neurons. 
NAA is reduced in conditions associated with neuronal loss, such as stroke or neuronal 
degenerative disorders. However, several studies have shown reversible decreases in NAA 
in a number of conditions have also been recognized, emphasizing that neuronal 
dysfunction can also lead to a decrease in NAA (Rudkin, Arnold, 1999). 2. Choline (Cho). 
Choline peak consists of choline, phosphocholine and glycerocholine. Cho is increased 
during increased cell -membrane turn over or during active myelin breakdown when these 
choline-containing membrane phospholipids are released. Increase Cho is detected in 
demyelination, remyelination, inflammation or gliosis (Rudkin, Arnold, 1999). 3. Creatine 
and phosphocreatine (Cr).Total creatine concentration is relatively constant throughout the 
brain , and  is used as an internal reference to normalize NAA and choline. Nevertheless 
there is loss of creatine in tissue necrosis (Rudkin, Arnold, 1999). 
When performing MRS with short TE (30-35 msec) some other metabolites could also be 
revealed, such as myo-inositol (mI), which is an osmolyte and astrocyte marker and is 
usually increased in demyelination, inflammation and gliosis. Lactate is elevated in 
anaerobic glycolysis and is not seen in normal brain spectra. The lactate peak is above the 
baseline when the TE is low (20–35 msec) or high (270–288 msec). At an intermediate TE 
(135–144 msec), the lactate peak inverts to project below the baseline, a feature that enables 
its distinction from lipids and some macromolecules seen at a similar location on the 
spectrum (1.35 parts per million). 
Commonly used spectroscopic techniques include the single- voxel spectroscopy which 
allows evaluation of only small volumes of tissue, and the multivoxel technique that allows 
examination of different areas of the brain at the same time and also permits the derivation 
of metabolite maps. The selection of appropriate MRS techniques, including measurement 
parameters such as repetition time (TR) and TE, depends on the clinical question. Short TE 
(20–35 msec) evaluations are required when there is a need for detection of metabolites with 
short relaxation times, such as glutamine, glutamate or  mI,  whereas studies with  long TE 
(135–270 msec) are sufficient for the detection of the major metabolites such as NAA, Cho, 
Cr, and lactate/lipids (Rudkin, Arnold, 1999) 
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Several studies have been performed using MRS in patients with SLE with or without 
neuropsychiatric manifestations. Most of them used single voxel MRS and proved reduction 
of the NAA/Cr and NAA/Cho ratios and elevation of Cho/Cr ratio in patients with SLE, 
not only in lesions, but also in normal-appearing white matter, when compared to controls. 
Nevertheless no dinstiction between acute and chronic disease has been demonstrated 
(Sibbit et al., 1997; Davie et al., 1995; Friedman et al., 1998). The NAA/Cr ratio was 
negatively correlated to the degree of atrophy in SLE patients, suggesting that cerebral 
atrophy in SLE in associated with neuronal damage (Sibbitt et al., 1994; Chinn et al., 1997). 
Decreased NAA/Cr ratio was found in white mater lesions of patients with NPSLE with no 
correlation with neurololgic or psyschiatric involvement (Davie et al., 1995). Patients with 
white matter lesions also had a more pronounced reduction in NAA/Cr ratio, when 
compared with patients without lesions, suggesting that neurophychiatric manifestations 
are associated with a complex multifocal and diffuse neurotoxic process (Brooks et al., 1999). 
Cerebrovascular abnormalities with small vessel injury, that underlie diffuse cerebral injury 
in SLE, (small focal lesions), are primarily associated with a decrease NAA/Cr ratio, while 
medium vessel injury is primarily associated with an increased Cho/Cr ratio (Friedman et 
al., 1998). It is well known that small focal lesions are also observed in healthy adults, often 
associated with older age. However, if neurometabolic changes are observed within these 
lesions, it could be inferred that these white matter lesions represent a serious pathologic 
process resulting in focal neuronal death or injury (Brooks et al., 1997). 
The amount of reduction in NAA/Cr ratio is associated with disease activity and the 
severity of clinical manifestations (Sibbitt et al., 1997).The same group failed to demonstrate 
lactate even in severely ill patients with major NPSLE, suggesting that extensive , anaerobic 
metabolism is not a fundamental characteristic of NPSLE, although this was contraindicated 
by others (Sundgren et al., 2005).They also found that increased lipid-macromolecules peaks 
at 1,2 ppm is an indicator of disease activity representing inflammatory cell infiltration, 
membrane activation, degradation or demyelination. Appenzeller and co-workers 
(Appenzeller et al., 2005) also demonstrated that the reduction in NAA /Cr ratio correlated 
with disease activity, independently of CNS manifestations, and that NAA/ Cr ratio in 
normal-appearing white matter returned to normal range after remission. 
Sabet and co-workers (Sabet et al., 1998) proved that NAA/Cr ratio was lower and Cho/Cr 
was higher in SLE patients with antiphospholipid antibody syndrome (aPLS) compared to 
those without aPLS . However thrombotic phenomena are most closely associated with the 
Cho/Cr ratio elevation in patients with SLE.  Elevated Cho/Cr ratio was observed in focal 
lesions and normal-appearing tissues of patients with SLE-aPLS consistent with infarct, 
activation of cellular membranes, catabolism of myelin, or inflammation. Cho/Cr ratio was 
increased in normal-appearing tissues, suggesting exaggerated injury to normal-appearing 
tissue in patients with SLE-aPLS consistent with widespread microinfarction. 
Reduction of NAA/Cr ratio and elevation of Cho/Cr ratio seem to reflect the cerebral 
metabolic disturbance related to the severity of neuropsychiatric symptoms regardless of the 
presence of abnormal MRI findings (Lim et al., 2000). In that study metabolic changes at the 
basal ganglia, besides the normal appearing white matter, was also found, indicating small 
vessel injury. Reduction of NAA/Cr ratio and elevation of Cho/Cr ratio in normal 
appearing white matter, related to the severity of neuropsychiatric symptoms was also 
proved by others (Axford et al., 2001; Handa et al., 2003; Castellino et al., 2005). Axford and 
co-workers also performed quantitative absolute assessment of the metabolites and found 
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increased absolute concentration of mI in NPSLE patients symptoms, that could be the 
result of inflammation, with a trend to be reversible in patients with minor. The authors 
suggest that raised mI, but normal NAA, that characterized SLE minor, may be due to result 
of vasculitis and inflammatory sequelae, which may be reversible if treated early enough. In 
contrast with the patients with SLE minor, the patients with SLE major had both increased 
mI and decreased NAA that may reflect gliosis and irreversible neuronal loss. 
Castellino and co-workers (Castellino et al., 2005) assessed metabolites at hypoperfused and 
normoperfused brain areas according to SPECT finding and found that NAA/Cr ratio was 
reduced in hypoperfused areas, and Cho/Cr ratio was elevated in normoperfused areas, 
while new white matter lesions were developed on previous areas of hypoperfusion and 
NAA/Cr ratio reduction indicating that increased Cho/Cr ratio in normal-appearing white 
matter may predict the appearance of white matter lesions. 
The NAA reduction has been also correlated with cognitive dysfunction and extent of brain 
damage (Sibbit et al., 1997; Lim et al., 2000). Increased choline was also associated with the 
presence of cognitive dysfunction in patients with SLE (Kozora et al., 2005) a finding that 
was further proved by other studies (Lapteva et al., 2006; Filley et al., 2009). Significant 
correlation was found between cognitive scores and higher Cho/Cr ratio of the dorsolateral 
prefrontal cortex and white matter (Lapteva et al., 2006) or the left frontal white matter 
(Filley et al., 2009).  
A recent study (Brooks et al, 2010) investigated most-mortem histopathological changes at 
autopsy in NPSLE patients and matched them voxel-by-voxel with the neurometabolites. 
They found that neurometabolite abnormalities were closely associated with underlying 
histopathological changes in the brain. Elevated choline levels were independently 
associated with gliosis, vasculopathy, and edema, while reduced creatine levels were 
associated with reduced neuronal–axonal density and gliosis. Reduced NAA levels were 
associated with reduced neuronal–axonal density and the presence of lactate was associated 
with necrosis, microhemorrhages, and edema. They suggest that altered neurometabolites in 
NPSLE patients, as determined by MRS, are a grave prognostic sign, indicating serious 
underlying histologic brain injury. 
Few studies incorporated a multisequence MRI approach in patients with NPSLE to 
investigate the relationship between the different non-conventional MRI techniques. Emmer 
and co-workers (Emmer et al., 2008) applied MTI and MRS in SLE and NPSLE patients and 
healthy controls and found that there was significant association between the MTR 
histogram peak height of the whole brain parenchyma and the white and gray matter and 
the NAA/Cr ratio, indicating that demyelination and neuronal/axonal damage often occur 
together in patients with a history of NPSLE. The Cho/Cr ratio showed no significant 
association with any MTR parameters. According to another study that investigated the 
relationship between magnetization transfer imaging (MTI), diffusion weighted imaging 
(DWI), proton magnetic resonance spectroscopy (H-MRS), and T2 relaxometry findings in 
patients with primary neuropsychiatric systemic lupus erythematosus (NPSLE) (Bosma et 
al., 2004), significant correlations were found between the different metrics and cerebral 
atrophy. The correlations between MTI and DWI parameters indicate that demyelination in 
NPSLE patients is associated with increased diffusivity, due to either to a breakdown of 
myelin or a discrete increase of CSF spaces-including perivascular changes-associated with 
cerebral atrophy. The association between prolonged T2 relaxation time and increased 
diffusivity could be based not only on atrophy, but also on the presence of gliosis.  
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5. Conclusion 
NPSLE is characterized by variable, focal or diffuse,  neuropsychiatric symptoms, leading to 
significant morbidity and mortality. NPSLE manifestations can occur in the absence of either 
serologic activity or other systemic lupus manifestations and there is no single sensitive and 
specific diagnostic test. Thus, in clinical practice the diagnosis of primary NPSLE is rather 
presumptive, after the exclusion of alternative causes of the neuropsychiatric symptoms. In 
patients with focal symptoms conventional MRI commonly detects small, discrete, 
hyperintense, frontal–parietal subcortical or periventricular white matter lesions, or even 
microhemorrhages, which are not specific for NPSLE and exhibit no clinical correlation. In 
diffuse NPSLE presentation conventional MRI could be totally unremarkable. 
Non- conventional MRI techniques, namely diffusion weighted imaging (DWI), diffusion 
tensor imaging (DTI), perfusion weighted imaging (PWI), Magnetization transfer imaging 
(MTI) and magnetic resonance spectroscopy (MRS) have been developed. These techniques 
are sensitive to microstructural (DWI, DTI,MTI ), hemodynamic (PWI) and biochemical 
(MRS) characteristics of the tissues, and could detect gray and white matter abnormalities in 
NPSLE patients, otherwise occult by conventional imaging. Vasculopathy is the most 
common pathologic finding in NSPLE, while true vasculitis is rather uncommon. SLE 
vasculopathy affects predominantly arterioles and capillaries and could be related to both 
acute inflammation and hypoperfusion resulting in ischemia, demyelination, axonal loss 
and gliosis. These pathologic findings lead to particular changes of the non-conventional 
MRI metrics, such as reduced increased diffusivity, decreased fractional anisotropy, 
decreased MTR values , decreased NAA levels, and elevated choline levels, not only in focal 
lesions but mostly in normal appearing white and gray matter in patients with NPSLE. 
These quantitative changes are related to disease activity and severity, cognitive 
performance, and also the presence of antiphospholipid antibody syndrome and/or   
anticardiolipin antibodies, while could affect with the prognosis of new lesions and clinical 
deterioration. Although there are some inconsistencies in the various reports published thus 
far reflecting heterogeneity in patient selection, sample size and diagnostic criteria used, , 
we believe that there is enough data to support the use in daily clinical practice at  tertiary 
care centers of non- conventional MRI techniques  for  the diagnostic work up of SLE 
patients with neuropsychiatric manifestations.  For places whereby these modalities are not 
available the EULAR guidelines recommend at a minimum an  MRI protocol (brain and 
spinal cord) that  includes conventional MRI sequences (T1/T2, FLAIR), diffusion-weighted 
imaging (DWI), and gadolinium-enhanced T1 sequences (Bertsias  et al., 2010).  
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